HEAD OF PRECLINICAL DEVELOPMENT

Jean-Pierre Riffaud, 59, was previously in charge of preclinical development at Cellpep, until the firm's recent acquisition by Canadian biotech company, Procyon Biopharma. Prior to that, he was senior project leader at NicOx, where he focused on preclinical development for clinical studies. Complementing this experience, Jean-Pierre Riffaud spent a major part of his career within mid-size French pharmaceutical groups, such as the Fournier Group and the Debat Laboratories. Jean-Pierre Riffaud has a PhD in Pharmacology from the School of Pharmacy, University of Paris and a diploma in Quality Assurance Management.